An interventional study of COPL participation in Pregnancy Loss, Early, Major Depression and Anxiety, sponsored by Amager Hospital. Active, not recruiting at 1 site in Denmark. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-06.
Sponsored by Amager Hospital · Not applicable, Interventional, and Prevention
Pregnancy loss is the most common severe pregnancy complication and is associated with significant mental health sequelae, including depression and anxiety. Standard care in Denmark does not include systematic follow-up or aetiological investigation after pregnancy loss. The Copenhagen Odense Pregnancy Loss (COPL) Cohort offered extensive aetiological investigations, and a dedicated clinical follow-up visit 4-10 weeks post-loss. This is a target trial emulation (TTE) designed to estimate the causal effect of COPL participation on women's mental health outcomes one year after pregnancy loss. We will emulate a target trial comparing (1) enrolment into COPL versus (2) standard pregnancy loss care. The study population comprises women aged ≥18 years with a confirmed intrauterine pregnancy loss (ICD-10: DO020, DO021, DO030-DO034) before 22 weeks' gestation treated at Danish public hospitals between November 2020 and April 2025. The primary outcome is new-onset affective disorder (ICD-10: F32*-F39*), neurotic/stress-related disorder (F41*, F43*, F48*), or dispensing of antidepressant (N06A*), anxiolytic (N05B*), or sedating (N05C*) medication within 12 months of pregnancy loss diagnosis. All data will be sourced from Danish National Registries. The difference-in-differences estimator will serve as the primary analytical approach, complemented by instrumental variable analysis (hospital of treatment as instrument) and regression discontinuity design. Inverse probability of treatment weighting will be used to control for measured confounders. Results will be reported as risk ratios and risk differences with 95% confidence intervals. Sensitivity analyses will include per-protocol estimation and exclusion of women with treatable findings identified in COPL.
221 studies on the registry are indexed under Abortion, Spontaneous; 44 are open to participants now.
This study's planned enrollment of 30,000 is above the median of 150 across 120 interventional studies indexed under Abortion, Spontaneous.
Browse Abortion, Spontaneous studies →Amager Hospital is the lead sponsor of 21 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Women with pregnancy loss participating in the COPL Cohort
Other: COPL participation
Women not included in the COPL cohort
Participation in the COPL cohort
New onset affective or stress-related disorder
Either ICD-10 F32\*-F39\*, F41\*, F43\*, F48\* registered or prescription of antidepressant, anxiolytic or sedating medication after PL
Time frame: 12 months after PL
Sick leave
Total number of sick-leave days
Time frame: First 12 months after PL
Health care utilization
Total GP use, referral to psychologist/psychiatrist
Time frame: 12 months after PL
Time to pregnancy
Time from time zero to next pregnancy
Time frame: Up to 12 months
Post-natal mood disorder
In case of subsequent delivery, prevalence of post-natal mood disorder
Time frame: Up to 12 months after time zero
Plan to share: No — It is not permitted
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Amager Hospital